Cellebrite director granted 15,190 RSUs

Cellebrite director Dafna Gruber received a new RSU grant that increases her direct equity holdings in CLBT.

Rhea-AI Filing Summary

Cellebrite DI Ltd. (symbol: CLBT) is the issuer of record for a Form 4 filing submitted to the SEC. Gruber Dafna reported acquisition or exercise transactions in this Form 4 filing.

Cellebrite DI Ltd. (CLBT) reported that director Dafna Gruber received an equity award of 15,190 restricted share units (RSUs) on September 17, 2026. The RSUs will vest on September 17, 2027, each settling into one ordinary share, bringing her directly held position to 43,109 ordinary shares.

Insider Trade Summary

Grant/Award: 15,190 shares

Grant/Award 1 txn

Insider Gruber Dafna

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary shares, par value NIS 0.00001 F1	15,190	$0.00	$0.00

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 43,109 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Key Figures

RSUs granted: 15,190 units Shares held after transaction: 43,109 shares Vesting date: September 17, 2027 +1 more

4 metrics

RSUs granted 15,190 units Restricted share units awarded to director Dafna Gruber on September 17, 2026

Shares held after transaction 43,109 shares Director Dafna Gruber’s directly held ordinary shares following the RSU award

Vesting date September 17, 2027 Scheduled vesting date for the 15,190 restricted share units

Award price per unit $0.00 per unit Equity compensation grant to director Dafna Gruber

Key Terms

restricted share units, RSUs, contingent right, Ordinary Share

4 terms

restricted share units financial

"Represents an award of restricted share units ("RSUs") that will vest"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

RSUs financial

"Represents an award of restricted share units ("RSUs") that will vest"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

contingent right financial

"Each RSU represents a contingent right to receive one Ordinary Share"

Ordinary Share financial

"Each RSU represents a contingent right to receive one Ordinary Share"

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cellebrite (CLBT) disclose for director Dafna Gruber?

Cellebrite disclosed that director Dafna Gruber received a grant of 15,190 restricted share units on September 17, 2026, each representing a right to receive one ordinary share upon settlement.

When do the newly granted RSUs to the Cellebrite (CLBT) director vest?

The 15,190 restricted share units awarded to director Dafna Gruber will vest on September 17, 2027, after which each unit is settled in one ordinary share of Cellebrite DI Ltd.

How many Cellebrite (CLBT) shares does Dafna Gruber hold after this Form 4 transaction?

Following the reported RSU award, director Dafna Gruber directly holds 43,109 ordinary shares of Cellebrite DI Ltd., as reported in the Form 4 filing.

Did the Cellebrite (CLBT) director buy shares on the market in this Form 4?

No. The Form 4 reports a grant of restricted share units to director Dafna Gruber at a stated price of zero, rather than an open-market purchase or sale.

Are the new Cellebrite (CLBT) RSUs for the director subject to settlement in shares?

Yes. Each of the 15,190 restricted share units granted to director Dafna Gruber represents a contingent right to receive one ordinary share of Cellebrite DI Ltd. upon settlement after vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 08:07 AM Accepted by SEC EDGAR 09/17/2026 - 08:06 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gruber Dafna

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	09/17/2026		A		15,190(1)	A	$0	43,109	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Remarks:

	/s/ Dafna Gruber	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)